Results 111 to 120 of about 47,532 (242)

Failure of bupropion to affect the response to tyramine in man. [PDF]

open access: bronze, 1981
AS Fowle, AW Peck, HJ Rogers, Spector Rg
openalex   +1 more source

Impact of Continuing Education on Clinicians' Self- Reported Knowledge of Tobacco Dependence and Tobacco Control Interventions [PDF]

open access: yes, 2018
Purpose: To assess a tobacco cessation continuing education (CE) program for Indiana dental and medical providers. Methods: A 26-item immediate post-CE survey and a 19-item 3-month follow-up survey assessed changes in participants’ self-reported ...
Coan, Lorinda, Romito, Laura M.
core  

Smartphone Application With Health Coaching Facilitates Multi‐Symptom Improvement in IBS Patients: A Pilot Feasibility Trial

open access: yesNeurogastroenterology &Motility, Volume 37, Issue 12, December 2025.
Benefits of a smartphone application and health coaching in IBS patients. ABSTRACT Background Irritable bowel syndrome (IBS), a disorder of the gut‐brain interaction, is associated with significant symptom burden and impaired psychosocial functioning.
Max Eisele   +6 more
wiley   +1 more source

Bupropion [PDF]

open access: bronze, 2019
T Arndt
openalex   +1 more source

Weight Loss‐Associated Remodeling of Adipose Tissue Immunometabolism

open access: yesObesity Reviews, Volume 26, Issue 12, December 2025.
ABSTRACT Obesity is a multifactorial condition characterized by excessive adiposity and systemic chronic low‐grade inflammation. Recent literature reflects a growing appreciation for the complex interplay between metabolism and the immune system in the pathogenesis of obesity‐related health conditions.
Paulo José Basso   +5 more
wiley   +1 more source

Bupropion

open access: yesReactions weekly, 2020

semanticscholar   +1 more source

Delphi Consensus Among French Obesity Experts on Clinical Recommendations for Drug Prescription in Patients With Severe Obesity

open access: yesObesity Reviews, Volume 26, Issue 12, December 2025.
ABSTRACT Introduction Although the physiologic alterations seen in obesity often affect the pharmacokinetics and pharmacodynamics of drugs, most clinical trials do not consider these aspects specifically for this population. To date, there is no list of potentially inappropriate medications for patients living with obesity. The aim of this study was to
Sarah Berdot   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy